false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Critica ...
Integrated Discussion and Audience Q&A
Integrated Discussion and Audience Q&A
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The panel concluded a day of talks on organ failure, dialysis, treatment timing and dose, and emerging biomarkers with an audience question-and-answer session.<br /><br />Discussion of furosemide stress testing highlighted its use when considering whether patients can come off continuous renal replacement therapy (CRRT), especially when fluid management is the main reason for dialysis. In end-of-life decisions, panelists recommended acknowledging prognostic uncertainty, using time-limited trials, offering anticipatory guidance, and sharing local outcomes data with families.<br /><br />Other topics included cardiac-surgery-associated AKI, albumin to augment diuretics, and acute peritoneal dialysis. Albumin may help in selected patients with very low serum albumin, though evidence is limited and benefits may be temporary. Acute PD can be valuable for hemodynamically unstable patients, but requires experienced teams and established protocols.<br /><br />Panelists also discussed niche uses of albumin dialysis, including as a bridge in liver failure or selected toxicities. They noted that adding urea during dialysis to reduce neurological effects has not been tested in humans. Post-diuretic urine sodium may help assess natriuretic response, but should be interpreted alongside the overall clinical picture. Finally, CRRT-associated dialysis disequilibrium is rare and supported mainly by case reports; avoiding rapid daily osmolar changes was advised.
Asset Caption
Faculty
Keywords
organ failure
continuous renal replacement therapy
furosemide stress test
acute kidney injury
albumin dialysis
peritoneal dialysis
dialysis disequilibrium
×
Please select your language
1
English